Collegium Pharmaceutical reported record third-quarter net revenues of $216.3 million, a 3% increase year-over-year, fueled by strong growth in its ADHD portfolio, including a 24% rise in JORNAY PM sales and $26.5 million in AZSTARYS revenue in its first full quarter under Collegium ownership. The company also announced a $50 million accelerated share repurchase program, reaffirmed its 2026 financial guidance, and highlighted ongoing efforts to support the ADHD community and expand its commercial reach. Despite a decline in its pain portfolio revenues, Collegium's adjusted EBITDA remained strong at $121.6 million. The company plans to complete the share buyback by year-end and participate in upcoming investor conferences.
Collegium Pharmaceutical's third quarter 2026 financial results provide context for readers interested in healthcare stocks. For readers following the health sector, here is Pluang's market snapshot as of Nov 05, 2026 19:01 WIB: out of 150 priced US health-sector stocks, 94 rose and 48 fell. Notable movers include Cigna Corp (CI) at USD 315.00 with a 3.14% increase and 100% buy order activity, Medpace Holdings Inc (MEDP) at USD 677.36 also up 3.14%, and Acadia Healthcare Company Inc (ACHC) at USD 33.26 rising 3.13% with 89% sell order activity.
Global tech giants like Amazon, Google, and Microsoft are committing hundreds of billions of dollars to expand AI-focused data center accelerators, driven by surging demand from generative AI workloads that exceed traditional CPU capabilities. These ...
Berkshire Hathaway's stock portfolio is now worth about three times what the company originally paid for it. These gains alone represent roughly 19% of Berkshire Hathaway's total company value, highlighting the significant growth and value generated ...
C3is Inc. will implement a one-for-five reverse stock split effective November 9, 2026, reducing its outstanding shares from about 4.2 million to 0.84 million. This move aims to increase the stock price to meet Nasdaq's minimum bid price requirement ...
Firmly secured $15 million in a Series A funding round led by Squarepoint Capital, with participation from J.P. Morgan Payments, Mastercard, and Samsung NEXT. The company provides a no-code platform that connects merchants to AI-driven shopping chann...
On November 4, 2026, Shell plc repurchased a total of 1,876,276 shares across multiple trading venues including LSE, Chi-X, BATS, XAMS, CBOE, and TQEX. The shares were bought at prices ranging from £37.98 to £38.82 and €45.70 to €46.72, with an avera...
